Product/Composition:- | Celecoxib Capsules |
---|---|
Strength:- | 50 mg, 100 mg, 200 mg, 400 mg |
Form:- | Oral Capsules |
Reference Brands:- | Celebrex(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Celecoxib selectively inhibits COX-2 enzyme, reducing prostaglandin synthesis responsible for pain and inflammation. It effectively treats arthritis and acute pain, offering benefits like targeted relief, fewer gastrointestinal side effects, and improved safety for long-term use. Its selective action maintains protective COX-1 functions, enhancing tolerability.
Celecoxib tablets are approved in the EU and US for managing rheumatoid arthritis, osteoarthritis, and acute pain. In the EU, brands like Celebrex (by Pfizer) are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on extensive clinical data with generic versions also available. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market entry for celecoxib tablets, ensuring adherence to European and American standards for safe, effective pain and inflammation management.